How to Buy Onkure Therapeutics Stock

Onkure Therapeutics Inc

OnKure, Inc. engages in the discovery and development of oncology-precision medicines for the treatment of cancer. The company focuses on developing selective inhibitors of histone deacetylases.

Onkure Therapeutics stock last closed at $2.73, down 5.54% from the previous day, and has increased 61.54% in one year. It has overperformed other stocks in the Biotechnology industry by 1.39 percentage points. Onkure Therapeutics stock is currently +118.4% from its 52-week low of $1.25, and -86.07% from its 52-week high of $19.60.

At the moment, there are 13.44M OKUR shares outstanding. The market capitalization of OKUR is $36.68M. In the last 24 hours, 119,850 OKUR shares were traded.

How to Buy Onkure Therapeutics Stock

Wondering how to invest in Onkure Therapeutics stock? Here's how.

  1. Decide where to buy Onkure Therapeutics stock: You need to decide on an online brokerage, but don't worry - we've analyzed dozens of stock brokerages and apps to help you decide where to buy Onkure Therapeutics stock.
  2. Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
  3. Put funds into your investment account: Pick your method of payment and add your info.
  4. Research Onkure Therapeutics stock: The Onkure Therapeutics ticker symbol is OKUR. Is Onkure Therapeutics stock a good investment? Should you buy shares of OKUR? How do OKUR's underlying business fundamentals look? Do top analysts think Onkure Therapeutics is a good buy? Why has OKUR's stock price moved recently? (Hint: Our stock market research website can help you figure out if OKUR is a good stock to buy).
  5. Make your OKUR buy order: Decide if you will purchase OKUR shares at the current market price or use a limit order to purchase OKUR shares at a particular price.
  6. Track your OKUR position: Create a watchlist to important notifications about your new investment in Onkure Therapeutics shares.

Step 1: Decide where to buy Onkure Therapeutics stock

You need a brokerage account to access the NASDAQ market and buy OKUR stock.

A brokerage account enables you to buy and sell a variety of financial instruments, such as stocks, bonds, mutual funds, and ETFs.

Our recommended brokerage: eToro

Based on our experience, eToro is the best stock brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without paying trading commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global markets: From Tech to Energy, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro boasts a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptocurrencies.

Get $10 towards your share purchase by creating an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for your brokerage account

Now that you've picked the best brokerage, it's time to fill out some personal info so you are able to invest in OKUR today.

How to Start a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Enter your personal info to start a new brokerage account.
  1. Send your data by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your investment account

Now that you've filled out your info on a mobile trading app, you can securely and quickly fund your account:

Check out this video walkthrough if you need help depositing funds into your new brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Onkure Therapeutics stock

Once you have figured out the best place to buy Onkure Therapeutics stock, it's crucial to research their stock prior to buying, so you actually wrap your head around the risk as well as the upside.

Onkure Therapeutics shares quick numbers

OKUR Price
$2.73
1w %
-10.2%
1y %
61.54%
5y %
N/A
P/E
-0.18x
P/B
0.35x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$52.67M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$36.68M
Next Earnings
May 5, 2025
Next Dividend
N/A

Onkure Therapeutics Due Diligence Score

WallStreetZen was created to help everyday investors do more in-depth fundamental analysis quickly.

You can view all of the due diligence checks on OKUR's stock page.

How is OKUR stock valued?

Investors use many financial metrics, analyses, models, and charts to gauge OKUR's fair value.

Using relative valuations ratios:

  • OKUR may be undervalued based on its P/B ratio of 0.35x, relative to Biotechnology industry P/B ratio of 4.04x

You can access additional valuation research on OKUR's stock here.

OKUR Financial Health Overview

Passed Financial Due Diligence Checks:

  • OKUR has cash burn of 51169000. It has sufficient cash and short-term investments to cover this for at least one year.
  • OKUR has $110.76M in cash and short term investments. This is enough to cover its annual cash burn of $51.17M.
  • There are more short-term assets than short-term liabilities on the OKUR balance sheet.
  • OKUR has a low debt to equity ratio of 0.11.
  • Total OKUR debt is lower than 5 years ago, relative to shareholder equity.
  • There are more short-term assets than long-term liabilities on the OKUR balance sheet.

Is Onkure Therapeutics stock a Buy, Hold, or Sell, according to analysts?

Out of 4 Wall Street analysts who monitor OKUR, the consensus analyst rating on Onkure Therapeutics is a Strong Buy

It's important to note that analyst forecasts are not stock recommendations, nor are they investment advice.

You can dig deeper into what analysts are saying on the Onkure Therapeutics stock forecast page.

OKUR Momentum

SMA10
2.98
SMA20
3.66
SMA50
4.56
SMA100
6.85
SMA200
6.82
MACD
-0.57
MACD Signal
-0.54
MACD Histogram
-0.03
RSI
17.07
Stochastic %K
13.86
Stochastic %D
16.48
StochRSI %K
22.62
StochRSI %D
24.08

Are OKUR executives and large shareholders buying or selling the stock?

Over the last 12 months, executives and large shareholders at OKUR have bought more shares than they have sold.

Jason A. Leverone, Chief Financial Officer of OKUR, was the latest OKUR insider to sell. They sold $4,925.32 worth of OKUR stock on Apr 7, 2025.

Get more info about who owns OKUR stock here.

Can I rely on OKUR as an income stream?

No, Onkure Therapeutics doesn't provide an income stream by paying out dividends.

Get opinions from other investors

One of the reasons eToro is our favorite brokerage is because of its social trading community.

Click below to learn what other investors have to say.

Step 5: Make your OKUR buy order

You have two main order types:

  • Market order: A market order is an order to buy or sell a stock at the best available price.
    Market orders are generally sufficient.
  • Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
    If you want to make sure you're buying or selling at an exact dollar amount limit, place a limit order.

Hit the Open Trade button and eToro will execute your order.

If you need additional info about buying stocks on eToro, watch the how to video below:

Open eToro Account

Step 6: Track your OKUR position

Now that you own some shares in OKUR, you'll want to keep up with your investment.

Create a watchlist to track your OKUR stock.

OKUR Feed

How to Buy Stock in Onkure Therapeutics

To reiterate, here are the 6 steps to buy Onkure Therapeutics stock:

  1. Decide where to buy Onkure Therapeutics stock
  2. Sign up for your brokerage account
  3. Put funds into your investment account
  4. Research Onkure Therapeutics stock
  5. Make your OKUR buy order
  6. Track your OKUR position

If you require a place to buy stocks, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you want to monitor your new investment in Onkure Therapeutics, add OKUR to your watchlist below.

NASDAQ: OKUR
$2.73-0.16 (-5.54%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.
NASDAQ: OKUR
$2.73-0.16 (-5.54%)
Updated Apr 21, 2025
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Onkure Therapeutics share?

As of Apr 21, 2025, it costs $2.73 to buy one share of Onkure Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $1, you can buy 0.366 shares of OKUR.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Onkure Therapeutics stock?

According to 4 Wall Street analysts who monitor Onkure Therapeutics, their consensus recommendation is to buy Onkure Therapeutics stock.

What is the best way to buy Onkure Therapeutics stock?

One way to place an order for Onkure Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.